162 related articles for article (PubMed ID: 20881771)
21. Significance of low levels of thyroglobulin in fine needle aspirates from cervical lymph nodes of patients with a history of differentiated thyroid cancer.
Borel AL; Boizel R; Faure P; Barbe G; Boutonnat J; Sturm N; Seigneurin D; Bricault I; Caravel JP; Chaffanjon P; Chabre O
Eur J Endocrinol; 2008 May; 158(5):691-8. PubMed ID: 18426828
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer.
Denizot A; Delfino C; Dutour-Meyer A; Fina F; Ouafik L
Thyroid; 2003 Sep; 13(9):867-72. PubMed ID: 14588101
[TBL] [Abstract][Full Text] [Related]
23. Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral blood.
Biscolla RP; Cerutti JM; Maciel RM
J Clin Endocrinol Metab; 2000 Oct; 85(10):3623-7. PubMed ID: 11061512
[TBL] [Abstract][Full Text] [Related]
24. Circulating thyroid cancer markers.
Gupta M; Chia SY
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468
[TBL] [Abstract][Full Text] [Related]
25. CIRCULATING THYROID-STIMULATING HORMONE RECEPTOR MESSENGER RNA AS A MARKER OF TUMOR AGGRESSIVENESS IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA.
Aliyev A; Gupta M; Nasr C; Hatipoglu B; Milas M; Siperstein A; Berber E
Endocr Pract; 2015 Jul; 21(7):777-81. PubMed ID: 25786552
[TBL] [Abstract][Full Text] [Related]
26. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
[TBL] [Abstract][Full Text] [Related]
27. Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer.
Grammatopoulos D; Elliott Y; Smith SC; Brown I; Grieve RJ; Hillhouse EW; Levine MA; Ringel MD
Mol Pathol; 2003 Jun; 56(3):162-6. PubMed ID: 12782763
[TBL] [Abstract][Full Text] [Related]
28. Circulating thyroglobulin mRNA does not predict early and midterm recurrences in patients undergoing thyroidectomy for cancer.
Lombardi CP; Bossola M; Princi P; Boscherini M; La Torre G; Raffaelli M; Traini E; Salvatori M; Pontecorvi A; Bellantone R
Am J Surg; 2008 Sep; 196(3):326-32. PubMed ID: 18614150
[TBL] [Abstract][Full Text] [Related]
29. Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission.
Fugazzola L; Mihalich A; Persani L; Cerutti N; Reina M; Bonomi M; Ponti E; Mannavola D; Giammona E; Vannucchi G; di Blasio AM; Beck-Peccoz P
J Clin Endocrinol Metab; 2002 Jul; 87(7):3201-8. PubMed ID: 12107225
[TBL] [Abstract][Full Text] [Related]
30. Differentiation of benign thyroid nodules from malignant thyroid nodules through miR-205-5p and thyroid-stimulating hormone receptor mRNA.
Zhou J; Cao L; Chen Z
Hormones (Athens); 2021 Sep; 20(3):571-580. PubMed ID: 33788150
[TBL] [Abstract][Full Text] [Related]
31. Molecular technology and the recombinant TSH have changed diagnostics of thyroid carcinoma with positive I-131 whole body scan but low serum thyroglobulin.
Montella L; Caraglia M; Abbruzzese A; Soricelli A; Prete SD; Squame G; Salvatore M
Exp Mol Med; 2004 Jun; 36(3):268-73. PubMed ID: 15272239
[TBL] [Abstract][Full Text] [Related]
32. Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels.
Castagna MG; Brilli L; Pilli T; Montanaro A; Cipri C; Fioravanti C; Sestini F; Capezzone M; Pacini F
J Clin Endocrinol Metab; 2008 Jan; 93(1):76-81. PubMed ID: 17971424
[TBL] [Abstract][Full Text] [Related]
33. Thyroglobulin mRNA quantification in the peripheral blood is not a reliable marker for the follow-up of patients with differentiated thyroid cancer.
Eszlinger M; Neumann S; Otto L; Paschke R
Eur J Endocrinol; 2002 Nov; 147(5):575-82. PubMed ID: 12444888
[TBL] [Abstract][Full Text] [Related]
34. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
Spencer CA; LoPresti JS; Fatemi S; Nicoloff JT
Thyroid; 1999 May; 9(5):435-41. PubMed ID: 10365673
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology.
Aliyev A; Patel J; Brainard J; Gupta M; Nasr C; Hatipoglu B; Siperstein A; Berber E
Surgery; 2016 Jan; 159(1):113-7. PubMed ID: 26454673
[TBL] [Abstract][Full Text] [Related]
36. Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients.
Duren M; Siperstein AE; Shen W; Duh QY; Morita E; Clark OH
Surgery; 1999 Jul; 126(1):13-9. PubMed ID: 10418587
[TBL] [Abstract][Full Text] [Related]
37. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood.
Ringel MD; Ladenson PW; Levine MA
J Clin Endocrinol Metab; 1998 Dec; 83(12):4435-42. PubMed ID: 9851791
[TBL] [Abstract][Full Text] [Related]
38. Circulating thyroid cancer biomarkers: Current limitations and future prospects.
Nixon AM; Provatopoulou X; Kalogera E; Zografos GN; Gounaris A
Clin Endocrinol (Oxf); 2017 Aug; 87(2):117-126. PubMed ID: 28493290
[TBL] [Abstract][Full Text] [Related]
39. Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma.
Giovanella L; Maffioli M; Ceriani L; De Palma D; Spriano G
Clin Chem Lab Med; 2009; 47(8):1001-4. PubMed ID: 19589104
[TBL] [Abstract][Full Text] [Related]
40. Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma.
Ausavarat S; Sriprapaporn J; Satayaban B; Thongnoppakhun W; Laipiriyakun A; Amornkitticharoen B; Chanachai R; Pattanachak C
Thyroid Res; 2015; 8():11. PubMed ID: 26244057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
